Entry Detail



General Information

Database ID:exR0755320
RNA Name:ABI3
RNA Type:mRNA
Chromosome:chr17
Starnd:+
Coordinate:
Start Site(bp):49210411End Site(bp):49223225
External Links:ENSG00000108798



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE106804
Description:Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:13
Number of Control:6
Number of Samples:19





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC010422.3
chr19
12643831
12648397
-
ANKRD46
chr8
100509752
100559784
-
CDC37
chr19
10391133
10420121
-
CFLAR
chr2
201116154
201176687
+
ETAA1
chr2
67397322
67412089
+
GRK2
chr11
67266473
67286556
+
HSPA8
chr11
123057489
123063230
-
LMNB2
chr19
2427638
2456959
-
MSN
chrX
65588377
65741931
+
MYL6B
chr12
56152256
56159647
+
PBK
chr8
27809624
27838082
-
PPP1R32
chr11
61481120
61490931
+
PPP4C
chr16
30075978
30085376
+
PTDSS2
chr11
448268
491399
+
RHOG
chr11
3826978
3840959
-
RPL8
chr8
144789765
144792587
-
RPS8
chr1
44775251
44778779
+
SKP1
chr5
134148935
134177038
-
TMEM216
chr11
61392360
61398863
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:NA
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:29330365
Title:Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.
Author:Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL.
Journal:Nat Commun. 2018 Jan 12;9(1):175.
Description:Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.